Abstract
This study investigates the effects of the anti-metabolite 5-fluorouracil (5-FU) on the human colon cancer line HT29 (10(7) cells per dose) grown subcutaneously in severe combined immunodeficient (SCID) mice. The efficacy of 5-FU was quantitatively evaluated by comparing the tumour weight, mitotic and apoptotic tumour cell indices and the expression of the Ki-67 nuclear antigen in drug-treated animals and control animals. The tumour cell carbohydrates were assessed using a lectin panel. A significant reduction in the tumour weight was found 4 days after initial 5-FU treatment. 5-FU treatment reduced the percentages of mitoses but increased the apoptotic index in the tumour cells. In addition, 5-FU induced an increase in the signet ring cell population and an increased binding for lectins specific for N-acetylgalactosamine and galactose. However, the vast majority of signet ring cells were negative for Ki-67. The results of this study indicate that continuous treatment with 5-FU for 4 days targets metabolic processes relevant for both cell division and apoptosis. The relative increase in the signet ring population can be explained by the fact that the more proliferation-active stem cell population of the tumour is the primary target of the therapy. The lectin-binding patterns reflect these changes and are therefore differentiation linked.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bengmark S., Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969 Jan;23(1):198–202. doi: 10.1002/1097-0142(196901)23:1<198::aid-cncr2820230126>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Buyse M., Zeleniuch-Jacquotte A., Chalmers T. C. Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA. 1988 Jun 24;259(24):3571–3578. [PubMed] [Google Scholar]
- Camplejohn R. S., Schultze B., Maurer W. An in vivo double labelling study of the subsequent fate of cells arrested in metaphase by vincristine in the JB-1 mouse ascites tumour. Cell Tissue Kinet. 1980 May;13(3):239–250. doi: 10.1111/j.1365-2184.1980.tb00463.x. [DOI] [PubMed] [Google Scholar]
- Camplejohn R. S., Schultze B., Maurer W. In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion. Br J Cancer. 1977 May;35(5):546–556. doi: 10.1038/bjc.1977.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Graaf T. W., Slot S. S., Peters G. J., Van Dijk W. Changes in glycosylation of L1210 cells after exposure to various antimetabolites. Eur J Cancer. 1993;29A(12):1760–1765. doi: 10.1016/0959-8049(93)90120-5. [DOI] [PubMed] [Google Scholar]
- Hindenburg A. A., Taub R. N., Grant S., Chang G., Baker M. A. Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells. Cancer Res. 1985 Jul;45(7):3048–3052. [PubMed] [Google Scholar]
- Ho S. B., Yan P. S., Dahiya R., Neuschwander-Tetri B. A., Basbaum C., Kim Y. S. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. J Cell Physiol. 1994 Aug;160(2):213–226. doi: 10.1002/jcp.1041600202. [DOI] [PubMed] [Google Scholar]
- Huet C., Sahuquillo-Merino C., Coudrier E., Louvard D. Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol. 1987 Jul;105(1):345–357. doi: 10.1083/jcb.105.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Imaizumi M., Kondo T., Taguchi T., Hattori T., Abe O., Kitano M., Wakui A. A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors. Surg Today. 1993;23(5):412–419. doi: 10.1007/BF00309499. [DOI] [PubMed] [Google Scholar]
- Momoi T., Shinmoto M., Kasuya J., Senoo H., Suzuki Y. Activation of CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase during the differentiation of HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem. 1986 Dec 5;261(34):16270–16273. [PubMed] [Google Scholar]
- Paulson J. C., Colley K. J. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem. 1989 Oct 25;264(30):17615–17618. [PubMed] [Google Scholar]
- Peters G. J., Pinedo H. M., Ferwerda W., de Graaf T. W., van Dijk W. Do antimetabolites interfere with the glycosylation of cellular glycoconjugates? Eur J Cancer. 1990 Apr;26(4):516–523. doi: 10.1016/0277-5379(90)90029-s. [DOI] [PubMed] [Google Scholar]
- Schumacher U., Adam E., Flavell D. J., Boehm D., Brooks S. A., Leathem A. J. Glycosylation patterns of the human colon cancer cell line HT-29 detected by Helix pomatia agglutinin and other lectins in culture, in primary tumours and in metastases in SCID mice. Clin Exp Metastasis. 1994 Nov;12(6):398–404. doi: 10.1007/BF01755883. [DOI] [PubMed] [Google Scholar]
- Schumacher U., Higgs D., Loizidou M., Pickering R., Leathem A., Taylor I. Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer. 1994 Dec 15;74(12):3104–3107. doi: 10.1002/1097-0142(19941215)74:12<3104::aid-cncr2820741207>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- Silverberg E., Lubera J. A. Cancer statistics, 1989. CA Cancer J Clin. 1989 Jan-Feb;39(1):3–20. doi: 10.3322/canjclin.39.1.3. [DOI] [PubMed] [Google Scholar]
- Williams G. T. Programmed cell death: apoptosis and oncogenesis. Cell. 1991 Jun 28;65(7):1097–1098. doi: 10.1016/0092-8674(91)90002-g. [DOI] [PubMed] [Google Scholar]
- Wyllie A. H. Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer. 1993 Feb;67(2):205–208. doi: 10.1038/bjc.1993.40. [DOI] [PMC free article] [PubMed] [Google Scholar]